The Korean Journal of Medicine

  • 제82권5호
  • /
  • Pages.562-568
  • /
  • 2012
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

76세 이상 노령자 폐암에서의 임상적 특징

Clinical Characteristics of Patients Older than 76 with Lung Cancer

  • 정선영 (충남대학교 의학전문대학원 내과학교실) ;
  • 박동일 (충남대학교 의학전문대학원 내과학교실) ;
  • 박명린 (충남대학교 의학전문대학원 내과학교실) ;
  • 정성수 (충남대학교 의학전문대학원 내과학교실) ;
  • 김주옥 (충남대학교 의학전문대학원 내과학교실) ;
  • 김선영 (충남대학교 의학전문대학원 내과학교실) ;
  • 이정은 (충남대학교 의학전문대학원 내과학교실)
  • Jung, Sun-Young (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Park, Dong-Il (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Park, Myoung-Rin (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Jung, Sung-Soo (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Kim, Ju-Ock (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Kim, Sun-Young (Department of Internal Medicine, Chungnam National University School of Medicine) ;
  • Lee, Jeong-Eun (Department of Internal Medicine, Chungnam National University School of Medicine)
  • 발행 : 2012.05.01
⟨ 이전 논문 다음 논문 ⟩

초록

목적: 폐암은 우리나라 암 사망원인에서 가장 높은 비율을 차지하는 질환이며 사회의 노령화에 따라 노인 폐암 환자는 증가하고 있지만, 실제로는 여러 이유로 적극적인 치료를 받지 못하는 경우가 많다. 이 연구에서는 76세 이상의 노인 폐암환자의 임상양상과 질병에 대한 병식에 대해 알아보고자 하였다. 방법: 2003년 1월부터 2010년 9월까지 충남대학교 병원에서 조직학적으로 폐암으로 확진을 받은 76세 이상인 환자를 대상으로 후향적인 연구를 하였다. 결과: 총 341명의 환자가 분석되었다. 중앙 나이 값은 79세였으며, 그중 80세 이상이 135명으로 39.6%를 차지하였다. 비소세포폐암 중 편평세포암이 가장 많은 비율을 차지하였다. 활동도의 경우 ECOG 0-1인 환자가 전체의 39.6%였다. 전체 환자 중 48%만이 치료를 받았으며, 병식이 있는 경우 치료를 받는 비율이 69.4%로 병식이 없는 경우에 비해 높았다. 결론: 노인 환자에서도 질병에 대한 정확한 지식과 이해를 통해 적극적인 치료를 시행하는 것이 바람직하다.

Background/Aims: A significant proportion of elderly patients who have lung cancer do not receive treatment even though they may benefit from it. The aims of this study were to analyze the clinical characteristics of elderly patients with lung cancer, especially those aged 76 years and older. Methods: In this retrospective study, we analyzed clinical data from 341 patients with lung cancer who were diagnosed at Chungnam National University Hospital from January 2003 to September 2010. Results: The median age of patients was 79 years (76-91), and 39.6% (n = 135) of the total sample were older than 80. Squamous cell carcinoma was the most common type of lung cancer, and the performance status (Eastern Cooperative Oncology Group [ECOG] 0-1) of 40.6% (n = 116) of the sample was good. Of the 293 non small cell lung cancer (NSCLC) patients, 53.6% were untreated. About 68% of all patients knew about their disease (n = 232). Conclusions: Our data indicated that many elderly patients with lung cancer were undertreated. Elderly patients with lung cancer should receive education to help them understand their disease and to encourage them to receive appropriate treatment.

키워드

참고문헌

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. https://doi.org/10.3322/canjclin.55.2.74
  2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
  3. Korea National Statistical Office. Annual Report on the Cause of Death Statistics 2007. Daejeon: Korea National Statistical Office, 2008.
  4. Kim YC, Kwon YS, Oh IJ, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer 2007;6:67-73. https://doi.org/10.6058/jlc.2007.6.2.67
  5. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials. Intern Med J 2006;36:216-220. https://doi.org/10.1111/j.1445-5994.2006.01033.x
  6. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-2726. https://doi.org/10.1001/jama.291.22.2720
  7. Jatoi A, Hillman S, Stella P, et al. Should elderly nonsmall- cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005;23:9113-9119. https://doi.org/10.1200/JCO.2005.03.7465
  8. Woo CM, Kim SY, Lee SA, et al. Paclitaxel for elderly patients with advanced NSCLC. Korean J Med 2006;70:183-189.
  9. Chen KY, Chen JH, Shih JY, Yang CH, Yu CJ, Yang PC. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors. J Thorac Oncol 2010;5:82-89. https://doi.org/10.1097/JTO.0b013e3181c09b28
  10. Altundag O, Stewart DJ, Fossella FV, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2007;2:141-146. https://doi.org/10.1097/01.JTO.0000282918.04853.62
  11. Spaggiari L, Scanagatta P. Surgery of non-small cell lung cancer in the elderly. Curr Opin Oncol 2007;19:84-91. https://doi.org/10.1097/CCO.0b013e32802b7041
  12. Tuckett AG. Truth-telling in clinical practice and the arguments for and against: a review of the literature. Nurs Ethics 2004;11:500-513. https://doi.org/10.1191/0969733004ne728oa
  13. Kim HS, Hyun DS, Kim KC, et al. The clinical characteristics and prognosis of elderly patients with lung cancer diagnosed in Daegu and Gyeongsangbukdo. Tuberc Respir Dis 2008;65:15-22. https://doi.org/10.4046/trd.2008.65.1.15
  14. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax 1996;51:564-568. https://doi.org/10.1136/thx.51.6.564
  15. Montella M, Gridelli C, Crispo A, et al. Has lung cancer in the elderly different characteristics at presentation? Oncol Rep 2002;9:1093-1096.
  16. Langer CJ. Clinical evidence on the undertreatment of older and poor performance patients who have advanced nonsmall- cell lung cancer: is there a role for targeted therapy in these cohorts? Clin Lung Cancer 2011;12:272-279. https://doi.org/10.1016/j.cllc.2011.02.001
  17. Wong AS, Teo C, Lim SW, Wong E, Soo RA, Chan N. Targeted therapy at the end of life for patients with lung cancer. J Palliat Med 2010;13:945-948. https://doi.org/10.1089/jpm.2010.0084
  18. Jo KH, An GJ, Kim GM. Future changes and directions for the construction of medical decision-making system in Korea: focused on Delphi Surveys. Korean J Med Ethics Edu 2011;14:131-144.

피인용 문헌

  1. Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-Small-Cell Lung Cancer in a Tertiary Referral Hospital vol.75, pp.2, 2012, https://doi.org/10.4046/trd.2013.75.2.52